126 related articles for article (PubMed ID: 16213525)
1. Androgen receptor binding sites identified by a GREF_GATA model.
Masuda K; Werner T; Maheshwari S; Frisch M; Oh S; Petrovics G; May K; Srikantan V; Srivastava S; Dobi A
J Mol Biol; 2005 Nov; 353(4):763-71. PubMed ID: 16213525
[TBL] [Abstract][Full Text] [Related]
2. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional analysis of consensus androgen response elements in human prostate cancer cells.
Horie-Inoue K; Bono H; Okazaki Y; Inoue S
Biochem Biophys Res Commun; 2004 Dec; 325(4):1312-7. PubMed ID: 15555570
[TBL] [Abstract][Full Text] [Related]
4. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract][Full Text] [Related]
6. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
7. A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron.
Steketee K; Ziel-van der Made AC; van der Korput HA; Houtsmuller AB; Trapman J
J Mol Endocrinol; 2004 Oct; 33(2):477-91. PubMed ID: 15525603
[TBL] [Abstract][Full Text] [Related]
8. Integrating genomic data to predict transcription factor binding.
Holloway DT; Kon M; DeLisi C
Genome Inform; 2005; 16(1):83-94. PubMed ID: 16362910
[TBL] [Abstract][Full Text] [Related]
9. Specific GATA-binding elements in the GnRH promoter are required for gene expression pulse activity: role of GATA-4 and GATA-5 in this intermittent process.
Leclerc GM; Bose SK; Boockfor FR
Neuroendocrinology; 2008; 88(1):1-16. PubMed ID: 18259093
[TBL] [Abstract][Full Text] [Related]
10. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
11. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
13. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
[TBL] [Abstract][Full Text] [Related]
14. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
15. A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes.
Böhm M; Locke WJ; Sutherland RL; Kench JG; Henshall SM
Oncogene; 2009 Oct; 28(43):3847-56. PubMed ID: 19684615
[TBL] [Abstract][Full Text] [Related]
16. Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4.
Wang J; Paradis P; Aries A; Komati H; Lefebvre C; Wang H; Nemer M
Mol Cell Biol; 2005 Nov; 25(22):9829-44. PubMed ID: 16260600
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
18. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
[TBL] [Abstract][Full Text] [Related]
19. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
Cai C; Hsieh CL; Shemshedini L
Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the TGF-beta1 promoter by androgen receptor.
Qi W; Gao S; Wang Z
Biochem J; 2008 Dec; 416(3):453-62. PubMed ID: 18651839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
